FY 2005 BJA Developing and Enhancing Prescription Drug Monitoring Programs

Document Type:	Grants Notice
Funding Opportunity Number:	DOJ-GRANTS-101304-001
Posted Date:	Oct 13, 2004
Original Due Date for Applications:	Jan 19, 2005
Current Due Date for Applications:	Jan 19, 2005
Archive Date:	Feb 18, 2005
Funding Instrument Type:	Grant
Category of Funding Activity:	Law, Justice and Legal Services
Expected Number of Awards:	Not Available.
Estimated Total Program Funding:	Not Available.
Award Ceiling:	none
Award Floor:	none
CFDA Number:	16.580 -- Edward Byrne Memorial State and Local Law Enforcement Assistance Discretionary Grants Program
Cost Sharing or Matching Requirement:	No

Eligible Applicants

State governments

Agency Name

Department of Justice, Headquarters, Office of Justice Programs

Description

The Bureau of Justice Assistance (BJA) announces the availability of grants to support the FY 2005 Developing and Enhancing Prescription Drug Monitoring Program.  BJA will determine the number of grants based on available resources, the number of submissions received the criteria set forth in this solicitation, and other considerations.  These grants will be determined through a competitive application process.  The purposes of this grant solicitation are: 1.) to fund projects that will enhance the capacity of regulatory and law enforcement agencies to collect and analyze controlled substance prescription drug data; and 2.) To fund projects that will provide help to states that want to establish a prescription drug monitoring program.  The maximum award for both programs - establishing a new program or enhancing an existing program - will be $350,000 for a minimum grant period of 15 months.

Prescription drug monitoring programs are systems where controlled substance dispensing data  is submitted to a centralized database administered by an authorized state agency.  These programs are designed to prevent and detect the diversion and abuse of pharmaceutically controlled substances, particularly at the retail level where no automated information collection system exists.  The increased efficiency of prescription drug monitoring programs allows for the early detection of abuse trends and possible sources of diversion.  The analysis of collected data also allows for the identification of outmoded prescribing practices, such as the under-treatment of pain, which may result in the development of educational programs for medical professionals.

Link to Full Announcement

http://www.ojp.usdoj.gov/BJA/grant/05PrescripDrugSol.pdf

If you have difficulty accessing the full announcement electronically, please contact:

Helpdesk, GMS, GMS Helpdesk, Phone 888-549-9901, Email helpdesk@ojp.usdoj.gov Helpdesk, GMS

• DOJ HQ listed by [Posted Date]
• DOJ Agencywide listed by [Posted Date]